8-KOther Events

BIOGEN INC. 8-K Report (Jul 17, 2003)

Filed July 17, 2003For Securities:BIIB

Summary

This Form 8-K filing by IDEC Pharmaceuticals Corporation, dated July 17, 2003, primarily serves to announce the company's financial results for the three months ended June 30, 2003. The report includes a press release (Exhibit 99.1) detailing these financial outcomes, alongside specific commentary on the presentation of non-GAAP financial information. Investors should note that the company believes this non-GAAP data offers a more effective comparison of ongoing operational results and trends, though it is not a substitute for Generally Accepted Accounting Principles (GAAP) reporting. The filing also confirms the company's legal name and its principal executive offices in San Diego, California.

Key Highlights

  • 1IDEC Pharmaceuticals Corporation filed a Form 8-K on July 17, 2003.
  • 2The primary purpose of the filing is to report financial results for the quarter ended June 30, 2003.
  • 3A press release dated July 17, 2003, containing the financial results, is attached as Exhibit 99.1.
  • 4The filing addresses the use of non-GAAP financial information, stating it's presented to aid in comparing ongoing operating results and trends.
  • 5IDEC Pharmaceuticals asserts that non-GAAP information is not a substitute for GAAP financial information.
  • 6The company's principal executive offices are located at 3030 Callan Road, San Diego, CA 92121.
  • 7Edward M. Rodriguez, Vice President, Finance and Controller, signed the report on behalf of the company.

Frequently Asked Questions

The main purpose of this Form 8-K filing is to report IDEC Pharmaceuticals Corporation's financial results for the three months ended June 30, 2003, through an attached press release.

The filing itself does not contain detailed financial statements directly within the 8-K document. It references a press release (Exhibit 99.1) that contains the financial results. Investors would need to refer to that press release for the specifics of the financial outcomes.

IDEC Pharmaceuticals Corporation believes that presenting certain information on a non-GAAP basis provides useful insights for both management and investors by allowing for a better comparison of ongoing operating results and trends. However, they emphasize that this non-GAAP information is not in accordance with, nor a substitute for, GAAP information.

The company's exact name as specified in its charter is IDEC Pharmaceuticals Corporation, and its principal executive offices are located at 3030 Callan Road, San Diego, CA 92121.